Published in Psychol Med on September 01, 2014
Marijuana Legalization: Impact on Physicians and Public Health. Annu Rev Med (2015) 0.86
The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia. Biol Psychiatry (2015) 0.76
Comorbid substance use disorders in schizophrenia: a latent class approach. Psychiatry Res (2014) 0.75
Utility of Washington Early Recognition Center Self-Report Screening Questionnaires in the Assessment of Patients with Schizophrenia and Bipolar Disorder. Front Psychiatry (2016) 0.75
Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia versus Non-Psychiatric Controls. Neuropsychopharmacology (2017) 0.75
The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein Predicts Cannabinoid-Antipsychotic Drug Interactions. Neuropsychopharmacology (2017) 0.75
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Schizophrenia. Lancet (2009) 8.14
Adverse health effects of non-medical cannabis use. Lancet (2009) 6.25
Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet (1987) 3.61
Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses. Nord J Psychiatry (2005) 3.22
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ (2002) 3.06
Early intervention for psychosis. Cochrane Database Syst Rev (2011) 3.04
Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ (2004) 2.93
Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol (2002) 2.80
Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ (2002) 2.74
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
Young cases of schizophrenia identified in a national inpatient register--are the diagnoses valid? Soc Psychiatry Psychiatr Epidemiol (2002) 2.63
Cannabis use predicts future psychotic symptoms, and vice versa. Addiction (2005) 1.89
Cannabis dependence and psychotic symptoms in young people. Psychol Med (2003) 1.80
Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand (2002) 1.60
Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. Am J Psychiatry (2010) 1.60
Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry (2008) 1.53
Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome. Schizophr Res (2006) 1.38
Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. Br J Psychiatry (2005) 1.20
Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Acta Psychiatr Scand (1989) 1.13
Validity of questionnaires in population studies on drug use. Acta Psychiatr Scand (1985) 1.08
Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm County. Acta Psychiatr Scand (1993) 1.05
A prospective evaluation of adherence to medication in first episode schizophrenia. Eur Psychiatry (2006) 1.03
The epidemiology of onset and course of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2000) 1.00
Function of male youths during military service. A follow-up study of a youth clientèle. Acta Psychiatr Scand Suppl (1980) 0.97
Non-psychotic psychiatric disorder and subsequent risk of schizophrenia. Cohort study. Br J Psychiatry (2000) 0.93
A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. Schizophr Res (2009) 0.91
A review of neuropsychological differences between paranoid and nonparanoid schizophrenia patients. Schizophr Bull (1998) 0.91
The subtyping of schizophrenia in men and women: a latent class analysis. Psychol Med (1994) 0.90
Early-onset schizophrenia. Neuropsychobiology (2012) 0.86
Acute and transient psychotic disorders (ICD-10 F23): a review from a European perspective. Eur Arch Psychiatry Clin Neurosci (2009) 0.85
Are there valid subtypes of schizophrenia? A grade of membership analysis. Psychopathology (2009) 0.81